Abstract:Renal fibrosis is a characteristic of progressive renal diseases leading to end‐stage renal failure. Induction of renal fibrosis via the mouse unilateral ureteral occlusion (UUO) model occurs within 5 days making it a high throughput model to evaluate novel therapeutic targets. Transforming growth factor‐beta (TGF‐β) is a key signaling molecule in the pathogenesis of renal fibrosis mediated through its actions on its receptor, Activin A Receptor‐Like Kinase (ALK5). Previously, we have shown the anti‐TGF‐β antibody (1D11; clone 1D11.16.8) attenuates UUO‐induced renal fibrosis. Here, we evaluated and compared the dose‐dependent ability of an orally‐available ALK5 inhibitor (SB‐525334) to attenuate UUO‐induced tissue biomarkers. To minimize the number of necessary control groups and ensure all mice were handled similarly, all mice received intraperitoneal injections of PBS or 3 mg/kg 1D11 QD d‐1 through d4 and oral gavage administration of vehicle or SB‐525334 (10, 30 or 100 mg/kg) QD d‐1 through d5. On d0, mice (male, CD‐1, 8–9 weeks age) underwent sham (n=8) or permanent total ligation of the right ureter (UUO, n=12–13/group) via aseptic laparotomy. Five days post‐UUO or sham surgery, renal tissue from sham or obstructed kidney was collected for analysis of profibrotic mRNA biomarker expression, TGF‐β content, hydroxyproline content and renal fibrosis as expressed as collagen volume fraction (CVF; quantitated via histological image analysis of Picrosirius Red stained mid‐transverse kidney sections). Consistent with a pathophysiological response to ureteral obstruction, UUO reliably (100%) elicited hydronephrosis. UUO increased renal cortical mRNA expression of several fibrotic markers—fibronectin‐1 (FN‐1; 3.4±0.5 fold induction from sham), alpha‐smooth muscle actin (α‐SMA; 0.9±0.2 fold), collagen 1A1 (Col1A1; 12.7±4.2 fold) and collagen 3A1 (Col3A1; 5.8±0.8 fold) as well as increased renal cortical TGF‐β content (2.8±0.2 fold), hydroxyproline content (1.6±0.1 fold) and CVF (8.8±0.9 fold). 1D11 attenuated UUO‐induced increases in FN‐1 (45.5±5.6%), Col1A1 (61.3±9.6%) and Col3A1 (48.6±8.2%) mRNA expression, TGF‐β content (38.8±5.9% inhibition), hydroxyproline content (23.4±6.5%), and CVF (42.6±5.7%). High dose (100 mg/kg) SB‐525334 attenuated UUO‐induced increases in FN‐1 (77.8 ±6.4%), α‐SMA (111.0±23.6%), Col1A1 (77.1±4.1%) and Col3A1 (56.0±7.8%) mRNA expression, as well as TGF‐β content (35.2±6.3%), hydroxyproline content (46.5±4.4%), and CVF (73.7±4.8% inhibition). The current data demonstrate the importance of TGF‐β signaling in fibrotic consequences of ureteral obstruction. Additionally, UUO‐induced renal injury can be modulated by a parenterally administered biological agent (1D11) as well as by an orally administered small molecule (SB‐525334) thus eliminating the need for multiple dosing routes in future UUO studies where a reference agent is utilized.

Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction

Effects of Transforming Growth Factor‐Beta (TGF‐β) Receptor I Inhibition on Renal Biomarkers and Fibrosis in Unilateral Ureteral Occluded (UUO) Mice.

Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction.

TGF-β1 receptor blockade attenuates unilateral ureteral obstruction-induced renal fibrosis in C57BL/6 mice through attenuating Smad and MAPK pathways

Inhibition of Renal Fibrosis by Gene Transfer of Inducible Smad7 Using Ultrasound-Microbubble System in Rat UUO Model.

THE EFFECT OF ALL-TRANS RETINOIC ACID ON TGF-β1/SMAD3 SIGNALING PATHWAY AFTER UNILATERAL URETERAL OBSTRUCTION OF RATS

[Dynamic Observation of Enalapril on the Expression of TGF-beta1, CTGF, Smad7 and Alpha-Sma in Rats with Unilateral Ureteral Obstruction].

[Effect of Astragalus Mongholicus on Expression of Transforming Growth Factor- Beta1 in SD Rats with Unilateral Ureteral Occlusion].

Effects of MMF on Expression of TGF-β1 and PAI-1 in Rats after Unilateral Ureteral Obstruction

Expression of Connective Tissue Growth Factor in Renal Interstitial Fibrosis after Unilateral Ureteral Obstruction in Rats

Expression of Connective Tissue Growth Factor in Renal Tubulointerstitial Fibrosis in Rats and Its Pathogenic Role

Effects of Ginkgo Leaf Extract and Diphyridamole Injection for Expression of Transforming Growth Factor β1 in Tubulointerstitial Fibrosis of Rats with Unilateral Ureteral Obstruction

Effect of Thymosin Β4 on Transforming Growth Factor-Β/connective Tissue Growth Factor of Renal Tubular Interstitial Fibrosis Rats

PATHOPHYSIOLOGY OF UNILATERAL URETERAL OBSTRUCTION: STUDIES FROM CHARLOTTESVILLE TO NEW YORK

[The Effect of Ginsenoside Rg1 on the Renal Interstitial Fibrosis of UUO Rat].

Effects of 1,25-dihydroxyvitamin D3 on the expression of macrophage chemotaxis inhibitory factor and nuclear factor-κB/P65 of tubulointersti-tial cells in unilateral ureteral ligation operation model rats

[Expression of P27 and TGF-beta in Rat Kidney with Unilateral Ureteral Obstruction and the Relationship Between TGF-beta and P27].

Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments

Attenuation of renal injury by administration of TK-850, a dual inhibitor of TGF{beta}R1/MAP4K4

Regulative effects of quercetin on transforming growth factor beta 1 and connective tissue growth factor in kidney tissue in rats with unilateral ureteral occlusion

Study of the expression of tissue transglutaminase and connective tissue growth factor in kidneys from UUO rats